Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece.

Skroumpelos A, Agorastos T, Constantinidis T, Chatzistamatiou K, Kyriopoulos J.

PLoS One. 2019 Dec 12;14(12):e0226335. doi: 10.1371/journal.pone.0226335. eCollection 2019.

2.

Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece.

Tentolouris A, Eleftheriadou I, Tzeravini E, Athanasakis K, Anastasiou IA, Kyriopoulos J, Tentolouris N.

Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1159-1164. doi: 10.1016/j.dsx.2019.01.030. Epub 2019 Jan 26.

PMID:
31336459
3.

Are happy people healthier? An instrumental variable approach using data from Greece.

Kyriopoulos I, Athanasakis K, Kyriopoulos J.

J Epidemiol Community Health. 2018 Dec;72(12):1153-1161. doi: 10.1136/jech-2018-210568. Epub 2018 Jul 20.

PMID:
30030297
4.

Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population.

Tentolouris A, Eleftheriadou I, Athanasakis K, Kyriopoulos J, Tsilimigras DI, Grigoropoulou P, Doupis J, Tentolouris N.

Hellenic J Cardiol. 2018 May 3. pii: S1109-9666(18)30038-1. doi: 10.1016/j.hjc.2018.04.008. [Epub ahead of print]

5.

Cost-effectiveness of Ingenol Mebutate Gel for the Treatment of Actinic Keratosis in Greece.

Athanasakis K, Boubouchairopoulou N, Tarantilis F, Tsiantou V, Kontodimas S, Kyriopoulos J.

Clin Ther. 2017 May;39(5):993-1002. doi: 10.1016/j.clinthera.2017.03.019. Epub 2017 Apr 24.

PMID:
28449867
6.

Subjective social status, social network and health disparities: empirical evidence from Greece.

Charonis A, Kyriopoulos II, Spanakis M, Zavras D, Athanasakis K, Pavi E, Kyriopoulos J.

Int J Equity Health. 2017 Feb 27;16(1):40. doi: 10.1186/s12939-017-0533-y.

7.

Cost Effectiveness of Apixaban versus Warfarin or Aspirin for Stroke Prevention in Patients with Atrial Fibrillation: A Greek Perspective.

Athanasakis K, Boubouchairopoulou N, Karampli E, Tarantilis F, Savvari P, Bilitou A, Kyriopoulos J.

Am J Cardiovasc Drugs. 2017 Apr;17(2):123-133. doi: 10.1007/s40256-016-0204-1.

PMID:
27882517
8.

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece.

Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J.

Clinicoecon Outcomes Res. 2016 Oct 12;8:583-590. eCollection 2016.

9.

Measuring the efficiency of the Greek rural primary health care using a restricted DEA model; the case of southern and western Greece.

Oikonomou N, Tountas Y, Mariolis A, Souliotis K, Athanasakis K, Kyriopoulos J.

Health Care Manag Sci. 2016 Dec;19(4):313-325. Epub 2015 Apr 26.

PMID:
25913830
10.

Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status.

Boubouchairopoulou N, Flouri I, Drosos AA, Boki K, Settas L, Zisopoulos D, Skopouli FN, Papadopoulos I, Iliopoulos A, Kyriopoulos J, Boumpas DT, Athanasakis K, Sidiropoulos P.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):999-1005. Epub 2016 Oct 7.

PMID:
27749220
11.

Economic crisis, austerity and unmet healthcare needs: the case of Greece.

Zavras D, Zavras AI, Kyriopoulos II, Kyriopoulos J.

BMC Health Serv Res. 2016 Jul 27;16:309. doi: 10.1186/s12913-016-1557-5.

12.

A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.

Karachaliou F, Athanasakis K, Tsentidis C, Soldatou A, Simatos G, Kyriopoulos J, Michalakos S, Karavanaki K.

Pediatr Diabetes. 2017 Aug;18(5):405-412. doi: 10.1111/pedi.12408. Epub 2016 Jul 22.

PMID:
27444352
13.

Factors associated with the utilization of mammographic screening in Greece.

Naoum P, Skroumpelos A, Athanasakis K, Kyriopoulos J.

Eur J Cancer Prev. 2018 Jan;27(1):13-19. doi: 10.1097/CEJ.0000000000000280.

PMID:
27439007
14.

How peptide technology has improved costs and outcomes in patients with heart failure.

Athanasakis K, Arista I, Balasopoulos T, Boubouchairopoulou N, Kyriopoulos J.

Expert Rev Pharmacoecon Outcomes Res. 2016 Jun;16(3):371-82. doi: 10.1080/14737167.2016.1187066. Review.

PMID:
27160541
15.

ESRD patients in Greece during the financial crisis.

Naoum P, Kitsonis D, Topkaroglou I, Skroumpelos A, Athanasakis K, Melexopoulou C, Iatrou C, Boletis J, Kyriopoulos J.

Int J Artif Organs. 2016 Jul 4;39(5):258-9. doi: 10.5301/ijao.5000495. Epub 2016 May 2. No abstract available.

PMID:
27140296
16.

Cost calculations during "dire straits": a cost-of-illness analysis of regular hemodialysis for end-stage renal disease in Greece.

Naoum P, Topkaroglou I, Kitsonis D, Skroumpelos A, Athanasakis K, Iatrou C, Boletis J, Kyriopoulos J.

Int J Artif Organs. 2016 Feb;39(2):87-9. doi: 10.5301/ijao.5000477. Epub 2016 Mar 7.

PMID:
26953901
17.

Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare setting.

Athanasakis K, Karampli E, Tsounis D, Bilitou A, Kyriopoulos J.

Clin Drug Investig. 2015 Nov;35(11):693-705. doi: 10.1007/s40261-015-0321-7.

PMID:
26385756
18.

Boceprevir for Chronic Genotype 1 Hepatitis C Virus in the Current Health Care Setting in Greece: A Cost-effectiveness Analysis.

Athanasakis K, Ferrante SA, Kyriopoulos II, Petrakis I, Hill M, Retsa MP, Kyriopoulos J.

Clin Ther. 2015 Jul 1;37(7):1529-40. doi: 10.1016/j.clinthera.2015.05.003. Epub 2015 May 29.

PMID:
26031617
19.

Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.

Athanasakis K, Tarantilis F, Tsalapati K, Konstantopoulou T, Vritzali E, Kyriopoulos J.

Rheumatol Int. 2015 Sep;35(9):1489-95. doi: 10.1007/s00296-015-3253-x. Epub 2015 Mar 21.

PMID:
25794569
20.

Quantifying the economic benefits of prevention in a healthcare setting with severe financial constraints: the case of hypertension control.

Athanasakis K, Kyriopoulos II, Boubouchairopoulou N, Stergiou GS, Kyriopoulos J.

Clin Exp Hypertens. 2015;37(5):375-80. doi: 10.3109/10641963.2014.977488. Epub 2014 Dec 12.

PMID:
25496288

Supplemental Content

Loading ...
Support Center